Literature DB >> 17854852

5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.

André G Oliveira1, Polyanna H Coelho, Fernanda D Guedes, Germán A B Mahecha, Rex A Hess, Cleida A Oliveira.   

Abstract

Prostate is one of the major targets for dihydrotestosterone (DHT), however this gland is also recognized as a nonclassical target for estrogen as it expresses both types of estrogen receptors (ER), especially ERbeta. Nevertheless, the concentrations of aromatase and estradiol in the prostate are low, indicating that estradiol may not be the only estrogenic molecule to play a role in the prostate. It is known that DHT can be metabolized to 5alpha-androstane-3beta,17beta-diol (3beta-diol), a hormone that binds to ERbeta but not to AR. The concentration of 3beta-diol in prostate is much higher than that of estradiol. Based on the high concentration of 3beta-diol and since this metabolite is a physiological ERbeta ligand, we hypothesized that 3beta-diol would be involved in the regulation of ERbeta expression. To test this hypothesis, adult male rats were submitted to castration followed by estradiol, DHT or 3beta-diol replacement. ERbeta and AR protein levels in the prostate were investigated by immunohistochemistry and Western blotting assays. The results showed that after castration, the structure of the prostate was dramatically changed and ERbeta and AR protein levels were decreased. Estradiol had just minor effects on the parameters analyzed. DHT-induced partial recovery of ERbeta while it was the most effective inductor of AR expression. Replacement with 3beta-diol-induced the highest levels of ERbeta, but was comparatively less effective in recovering the AR expression and the gland structure. These results offer evidence that one functional role of 3beta-diol in the prostate may be autoregulation of its natural receptor, ERbeta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854852     DOI: 10.1016/j.steroids.2007.08.001

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  22 in total

Review 1.  Roles of oestrogen receptors alpha and beta in behavioural neuroendocrinology: beyond Yin/Yang.

Authors:  E F Rissman
Journal:  J Neuroendocrinol       Date:  2008-06       Impact factor: 3.627

Review 2.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

3.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.

Authors:  Paul Mak; Irwin Leav; Bryan Pursell; Donggoo Bae; Xiaofang Yang; Cherie A Taglienti; Lindsey M Gouvin; Vishva M Sharma; Arthur M Mercurio
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

4.  New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice.

Authors:  Chieh V Chen; Jennifer L Brummet; Joseph S Lonstein; Cynthia L Jordan; S Marc Breedlove
Journal:  Horm Behav       Date:  2014-01-15       Impact factor: 3.587

Review 5.  Estrogens in Male Physiology.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; CheMyong Ko; Gail S Prins; Rex A Hess
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

6.  17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.

Authors:  Juliette A Aka; Mausumi Mazumdar; Chang-Qing Chen; Donald Poirier; Sheng-Xiang Lin
Journal:  Mol Endocrinol       Date:  2010-02-19

7.  Facilitation of male sexual behavior in Syrian hamsters by the combined action of dihydrotestosterone and testosterone.

Authors:  David J Piekarski; Ned J Place; Irving Zucker
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

8.  Androgenic regulation of ventral epithelial bud number and pattern in mouse urogenital sinus.

Authors:  Sarah H Allgeier; Tien-Min Lin; Robert W Moore; Chad M Vezina; Lisa L Abler; Richard E Peterson
Journal:  Dev Dyn       Date:  2010-02       Impact factor: 3.780

9.  The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.

Authors:  Matthew J Sikora; Kevin E Cordero; Jose M Larios; Michael D Johnson; Marc E Lippman; James M Rae
Journal:  Breast Cancer Res Treat       Date:  2008-06-04       Impact factor: 4.872

10.  Long-term inhibition of 5-alpha reductase and aromatase changes the cellular and extracellular compartments in gerbil ventral prostate at different postnatal ages.

Authors:  Lara S Corradi; Silvana G P Campos; Fernanda C A Santos; Patricia S L Vilamaior; Rejane M Góes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.